Regulation of IgE Response by Antiidiotypes and Adjuvants
In a symposium organized under the title of New Trends in Allergy, it may be suitable to start by discussing some of the new concepts which have emerged during the past 3 or 4 years about the management and manipulation of allergic diseases, in particular of diseases due to IgE antibodies. Admittedly, many of these new approaches are still of an experimental nature and have not yet had a full impact on the therapy of allergy in man. However, some of these experiments bring about a new understanding of the mechanisms underlying allergic disease and they are bound, in my opinion, to profoundly influence the development of allergy diagnosis and therapy in the years to come.
KeywordsHydroxide Trypsin Myeloma Pertussis Mycobacterium
Unable to display preview. Download preview PDF.
- 1.Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol (Paris) 125C: 373–389Google Scholar
- 4.Blaser K, Nakagawa T, Weck AL de (to be published) Suppression of the benzylpenicilloyl (BPO)-specific IgE formation with isologous anti-idiotypic antibodies in Balb/C mice. J ImmunolGoogle Scholar
- 5.Blaser K, Nakagawa T, Weck AL de (to be published) Suppression of the anti-hapten and anti-carrier IgE response by anti-carrier (ovalbumin) anti-idiotypes in Balb/C miceGoogle Scholar